-+ 0.00%
-+ 0.00%
-+ 0.00%

Ernexa Therapeutics holds annual shareholder meeting

PUBT·07/02/2026 20:32:44
Listen to the news
Ernexa Therapeutics holds annual shareholder meeting
  • Ernexa Therapeutics held its annual stockholder meeting on July 1, 2027.
  • Stockholders elected five directors to serve until the 2027 annual meeting.
  • Appointment of Haskell & White LLP as independent registered public accounting firm for fiscal 2026 was ratified.
  • Adoption of the 2026 Ernexa Therapeutics Omnibus Equity Incentive Plan was approved.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031920), on July 02, 2026, and is solely responsible for the information contained therein.